Review Article
Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Table 1
General characteristics of the noncontrolled single-arm LMGB studies.
| | Study characteristics | Baseline patient demographics | 1-year postoperative results | | Author | Year | Region | Number
(M/F) | Age
(range) | BMI
(kg/m2) | Weight
(kg) | WC (cm) | T2DM
patients | %EWL | BMI (kg/m2)/ΔBMI | Weight/weight loss (kg) | Remission or improvement of T2DM |
| |
Carbajo et al. [18] | 2005 | Spain | 209
(37/172) | 41
(14–66) | 48
(39–86) | NR | NR | NR | 75%, 80% at 18 months | NR/NR | NR/NR | NR |
| | Rutledge and Walsh [19] | 2005 | USA | 2410
(361/2049) | 39
(14–78) | 46 ± 7
(34–74) | NR | NR | 24% | 80% | 29/NR | NR/59 | 83% |
| | Wang et al. [20] | 2005 | Taiwan | 423
(87/336) | 30.6 ± 9.3
(19–62) | 44.2 ± 7
(35.5–72.1) | 120.3 ± 23.4
(89–212.7) | NR | 79 | 69.3% | 29.2/NR | NR | 100% |
| | Chakhtoura et al. [22] | 2008 | France | 100
(23/77) | 40.9 ± 11.5
(17.5–62.4) | 46.9 ± 7.4
(32.8–72.4) | 131 ± 23.1
(82–203) | NR | None | 63 ± 14% | 31.9 ± 5.7/NR | 89.8 ± 18.4/NR |
NR |
| | Lee et al. [23] | 2008 | Korea | 44 (6/38)
114 (33/81)
43 (19/24) | 39 ± 8.9
34.8 ± 9.2
28.2 ± 8.7 | 31.7 ± 2.7
40 ± 2.8
51.4 ± 6 | 143.1 ± 9.8
107.6 ± 5.1
81.2 ± 5.1 | 103.4 ± 7.1
117.6 ± 14.7
137.8 ± 15.3 | All | NR | NR/8.5 ± 2.2
NR/12.4 ± 3.2
NR/17.9 ± 5.8 | 91.4 ± 9.8/NR
79.2 ± 5.5/NR
60.4 ± 3.3/NR | 87.1% |
| | Peraglie [25] | 2008 | USA | 16
(2/14) | 40
(27–61) | 62.4
(60–73) | 166
(150–193) | NR | NR | 57%, 65% at 2 years | NR | NR/63 | NR |
| Kim and Hur
[26] | 2011 | Korea | 10
(2/8) | 46.9
(29–59) | 27.2
(25.3–29.9) | NR | NR | All | NR | NR/23.4
(21.3–25.6) | NR/NR | 70% |
| | Piazza et al. [27] | 2011 | Italy | 197
(50/147) | 37.9
(20–55) | 52.9 | NR | NR | NR | 65%, 80% at 2 years | 39.4 ± 4.2/NR | NR/NR | 90% |
| | Noun et al. [28] | 2012 | Lebanon | 923
(315/606) | 32.77 ± 10
(13–70) | 42.5 ± 6.39
(35–75) | 121.64 ± 23.85
(80–240) | NR | 19% | 69.9% ± 23.1% | 28.3 ± 4.8/NR | 80.3 ± 14.2/NR | 85% |
| | Kim and Hur [29] | 2014 | Korea | 107
(54/53) | 46 ± 11
(21–74) | 25.3 ± 3.2
(18–30) | NR | NR | All | NR | 22.9 ± 3.0/NR | NR/NR | 53%, 63% at 2 and 90% at 3 years |
| | Kular et al. [31] | 2014 | India | 1054
(342/712) | 38.4 ± 9.6 | 43.2 ± 7.4 | 128.5 ± 25.2 | 118.2 ± 15.7 | 674 (64%) | 85%, 91% at 2 and 85% at 5 years | 26.2 ± 3.1/NR | NR | 93.2% of remission;
98% of improvement |
| | Musella et al. [32] | 2014 | Italy | 974
(475/499) | 39.4 | 48 ± 4.58 | NR | NR | 224 (22.9%) | 70.12 ± 8.35%, 77% at 5 years | 31.88 ± 4.91/NR | 91.5 ± 18.5/NR | 87%, 84.4% at 5 years |
|
|
NR: not reported; postoperative results at 6 months.
|
